Medical advertising is paid promotion of health services, drugs, medical devices and health products to patients or clinicians. In the United States it is governed by the FTC (truthful, substantiated claims), the FDA (prescription drug ads), HIPAA (how patient information may be used for marketing), state laws and each ad platform’s health policies, which decide whether an ad runs.
Below are the rules in one table, sourced examples and published costs. We have worked only in healthcare since 2005; this is general information, not legal advice.
What counts as medical advertising?
Any paid message that promotes a health service or product, from a clinic’s search ad to a drug maker’s TV commercial. Who regulates it depends on what is being sold. The FDA’s Office of Prescription Drug Promotion reviews prescription drug promotion to make sure it is “truthful, balanced, and accurately communicated.” For supplements, over-the-counter drugs, diagnostic tests, health apps and other health products, the FTC polices the advertising claims; its Health Products Compliance Guidance explains how it splits that work with the FDA. HIPAA does not regulate what an ad says. It limits what a hospital, practice or health plan may do with patient information to target or measure one.
What rules govern medical ads in 2026?
Platforms stop an ad before it runs; regulators usually act after. As of September 2026:
| Rule | Applies to | What it requires | Source |
|---|---|---|---|
| Google Ads healthcare and medicines policy | Pharmacies, telemedicine, prescription drugs, addiction treatment, experimental treatments | In the U.S., addiction treatment needs LegitScript certification; online pharmacies need LegitScript or NABP, and telemedicine that facilitates prescribing needs LegitScript, plus Google’s own certification. Speculative and experimental treatments are barred (narrow exception for FDA-approved cell and gene therapies). | Google Ads Help |
| Google personalized advertising policy | Targeting for ads about health conditions and their treatment, intimate health, invasive procedures, disabilities | A sensitive category: no Customer Match, remarketing lists (your data segments), audience expansion or lookalikes. Google’s predefined audiences, such as in-market and location, are allowed. | Google Ads Help; health |
| Meta advertising standards | Ad text and creative on Facebook and Instagram | No copy that asserts or implies a health condition (“Do you have diabetes?” is out, “Depression counseling” is fine). Weight-loss and cosmetic procedure ads must target 18+. Prescription drug ads from online pharmacies and telehealth need LegitScript and may target only adults in the U.S., Canada and New Zealand. U.S. addiction treatment ads need LegitScript and Meta’s written permission. | Attributes; wellness; drugs; addiction |
| Meta Business Tools Terms, section 1.h | Meta Pixel, Conversions API, custom audiences | No data that includes or is based on health information, and no event, conversion or audience names that imply it. | Meta terms |
| FTC Act and Health Products Compliance Guidance (December 2022) | Health claims for supplements, OTC drugs, tests, apps and other health products | Truthful claims backed by competent and reliable scientific evidence, generally randomized, controlled human clinical trials for health benefits. The FTC also polices health data: its 2023 GoodRx action carried a $1.5 million civil penalty. | FTC guidance; GoodRx |
| FDA: 21 CFR 202.1, enforced by OPDP | Prescription drug ads | A true brief summary of side effects, contraindications and effectiveness, in fair balance. TV and radio ads must present the “major statement” of major side effects and contraindications clearly, conspicuously and neutrally (compliance date November 20, 2024). | 21 CFR 202.1; final rule |
| HIPAA Privacy Rule and HHS online tracking guidance | Providers and health plans (covered entities) and their business associates | Patient authorization before PHI is used or disclosed for marketing, including to tracking vendors. A June 20, 2024 court ruling vacated the guidance’s part on IP addresses and unauthenticated public pages; HHS withdrew its appeal. | 45 CFR 164.508; HHS; AHA News |
| Washington My Health My Data Act | Consumer health data, including businesses HIPAA doesn’t cover | Consent to collect or share consumer health data (since March 31, 2024; June 30, 2024 for small businesses). No geofence within 2,000 feet of an in-person health care facility to track visitors, collect their data or send them health ads. | WA AG; RCW 19.373.080; .010 |
On September 9, 2025 the FDA announced roughly 100 cease-and-desist letters and thousands of letters telling drug companies to remove misleading ads. The same day it sent Hims & Hers a warning letter over website claims for compounded semaglutide. FDA’s regulatory agenda also lists a proposed rule, targeted for December 2026, that would end the option of meeting the brief summary requirement in TV and radio ads by pointing viewers to another source outside the ad.
For how to structure paid search around these limits, see our compliance-first guide to healthcare SEM and PPC.
What are good examples of medical ads?
Each row has a source, and unpublished results are marked. Some rows show what went wrong. The campaigns belong to the brands named, not to 210.
| Advertiser and campaign | Year | Channel | What the ad did | What happened | Source |
|---|---|---|---|---|---|
| Boehringer Ingelheim: “Detect the SOS” | 2025–2026 | Super Bowl LX TV (30 seconds), influencers | Asked people with type 2 diabetes or high blood pressure to ask their doctor about a urine test (uACR) | 2.1× median engagement (EDO); screening results not publicly reported | MM+M; EDO |
| Viatris (Viagra): “Make Love Last” | 2025 (award year) | Unbranded video by Ogilvy Shanghai | Promoted Viagra where pharma ads are banned: couples filmed in time-lapse, so intimacy shows only as a blur | Pharma Grand Prix, Cannes Lions 2025 | MM+M |
| Ad Council: “Love, Your Mind” | 2023–2025 | Donated-media PSAs: TV, video, outdoor, radio, digital | Encouraged people to be more open and proactive about their mental health (English and Spanish) | $90M+ donated media, 2.2M+ website visits, 49% awareness among U.S. adults 18–44 (Ad Council research, late 2025) | Ad Council |
| Hims & Hers: “Sick of the System” | 2025 | Super Bowl LIX TV (60 seconds) | Promoted compounded GLP-1 treatment with a voiceover critiquing the pharma industry | EDO rated it fifth (7.7× median engagement), USA Today Ad Meter 49th; two senators asked the FDA to review it, citing a risk of omitting safety information | MM+M |
| Hims & Hers: hims.com semaglutide pages | 2025 | Website | Described compounded semaglutide as “Same active ingredient as Ozempic and Wegovy” and “Clinically proven ingredients” | FDA warning letter (September 9, 2025): compounded drugs are not FDA-approved; claims false or misleading | FDA |
| BetterHelp: podcast advertising | 2024 | Podcast ads | Heavy podcast ad spending | Top podcast advertiser in Magellan AI’s August 2024 report ($6.45M). A 2023 FTC order: $7.8M and a ban on sharing health data for advertising | Radio Ink; FTC |
What these examples teach
- Ask for one action. Boehringer Ingelheim asked for a test, not a promised outcome, which is also the easier claim to support.
- Scrutiny follows reach. A national spot for a compounded drug drew a request for FDA review, and the company’s website claims later drew a warning letter.
- Data use is regulated too. BetterHelp’s FTC order was about what it shared with ad platforms, not what its ads said.
For more, see 12 successful healthcare marketing campaigns to study in 2026.
How much does medical advertising cost?
Specialty, city, channel and competition all move the price, so there is no single number. Published figures:
- Search ads: LocaliQ’s healthcare search ads benchmark (a vendor study of 3,542 U.S. campaigns, October 2024 to September 2025, reporting medians) puts healthcare at $5.64 per click and $66.02 per lead.
- By specialty: from $2.29 per click (emergency medicine) to $8.76 (orthodontics), and from $18.54 per lead (dermatology) to $141.17 (mental health); addiction recovery was $120.30 per lead.
- Certification: LegitScript’s addiction treatment certification costs $1,395–$1,595 to apply and $2,550–$3,095 a year per facility (less for eligible individual practitioners).
- National TV: MM+M put a 30-second Super Bowl LX spot at around $8 million.
Treat a benchmark as a sanity check, not a forecast. A lead is not a patient; cost per booked patient depends on your landing page, how fast calls are answered and whether tracking can tell a booking from a page view. Our healthcare paid media work plans budgets from those numbers, market by market.
How do you run medical ads without breaking the rules?
- Get certified first. Addiction treatment, online pharmacies and telehealth prescribing need LegitScript and platform approval before any ad runs.
- Write to the service, not the person. “Depression counseling” can run; Meta lists “Depression getting you down? Get help now.” as what can’t.
- Keep a substantiation file. If you can’t document an outcome claim, advertise access instead.
- For prescription drugs, keep the risks in the ad, and never imply a compounded drug is FDA-approved.
- Keep patient data out of ad platforms. No conditions in URLs, event or audience names; count conversions server-side; sign a business associate agreement with any vendor that receives PHI. Our HIPAA-aware analytics and attribution work is built around this. We sign a business associate agreement whenever an engagement touches protected health information, and we design programs so that most of them never need to.
- Check state law before you geofence. Washington bars geofences within 2,000 feet of a health care facility used to track visitors or send them health ads.
Medical advertising FAQ
Is medical advertising legal in the United States?
Yes. The limits are on what an ad claims, who it targets and what patient data it uses. Claims must be truthful and substantiated, prescription drug ads must present risk information, and Google and Meta add their own rules.
Who regulates medical ads?
The FDA regulates prescription drug ads. The FTC polices claims for supplements, over-the-counter drugs, health apps and other health products. HHS enforces HIPAA, which limits how providers and health plans use patient information for marketing. States such as Washington add their own laws.
Can healthcare advertisers use remarketing?
Usually not on Google. For ads about health conditions and their treatment, invasive procedures and similar topics, its personalized advertising policy bars Customer Match, remarketing lists, audience expansion and lookalikes. Meta’s Business Tools Terms bar sending health information through its pixel. Keywords, location and Google’s predefined audiences remain available.
Do you need LegitScript certification to run medical ads?
For some categories. In the U.S., Google and Meta require it for addiction treatment ads and for online pharmacies and prescribing telehealth (Google also accepts NABP accreditation for pharmacies). Routine care, such as a primary care visit, is not one of the categories these policies list.
Does HIPAA apply to medical advertising?
It applies when a hospital, practice or health plan, or its business associate, uses patient information. Using or disclosing protected health information for marketing, including to tracking vendors, needs the patient’s authorization. A 2024 court ruling narrowed HHS’s tracking guidance for public pages but did not change that rule.
Planning medical ads for your practice or health system? Book a call with 210 Digital Marketing and we will go through the rules that apply to your specialty and market.
How we research and fact-check: every statistic links to its source. Read our editorial standards.
